INS and Insulin resistance: Metformin addresses insulin resistance primarily in the liver and skeletal muscle and mainly reverses hyperglycaemia through a reduction in hepatic glucose production, while the thiazolidinediones increase whole-body insulin-mediated glucose disposal to a greater extent than metformin (8).